163 related articles for article (PubMed ID: 20535989)
1. [Clinicopathological study of the 1973 who classification and the WHO/ISUP classification in pTa bladder carcinoma].
Ishida R; Tsuzuki T; Yoshida S; Shiota T; Nisikimi T; Yamada H; Yokoi K; Kobayashi H
Nihon Hinyokika Gakkai Zasshi; 2010 May; 101(4):609-14. PubMed ID: 20535989
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
[TBL] [Abstract][Full Text] [Related]
3. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.
Samaratunga H; Makarov DV; Epstein JI
Urology; 2002 Aug; 60(2):315-9. PubMed ID: 12137833
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma.
Cao D; Vollmer RT; Luly J; Jain S; Roytman TM; Ferris CW; Hudson MA
Urology; 2010 Sep; 76(3):593-9. PubMed ID: 20381131
[TBL] [Abstract][Full Text] [Related]
5. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors.
Pellucchi F; Freschi M; Ibrahim B; Rocchini L; Maccagnano C; Briganti A; Rigatti P; Montorsi F; Colombo R
J Urol; 2011 Dec; 186(6):2194-9. PubMed ID: 22019037
[TBL] [Abstract][Full Text] [Related]
6. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?
Gontero P; Gillo A; Fiorito C; Oderda M; Pacchioni D; Casetta G; Peraldo F; Zitella A; Tizzani A; Ricceri F
Urol Int; 2014; 92(2):136-42. PubMed ID: 24080613
[TBL] [Abstract][Full Text] [Related]
9. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression.
Vardar E; Gunlusoy B; Minareci S; Postaci H; Ayder AR
Urol Int; 2006; 77(1):27-33. PubMed ID: 16825812
[TBL] [Abstract][Full Text] [Related]
11. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.
Nishiyama N; Kitamura H; Maeda T; Takahashi S; Masumori N; Hasegawa T; Tsukamoto T
Jpn J Clin Oncol; 2013 Nov; 43(11):1124-31. PubMed ID: 23980236
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of KAI1 metastasis suppressor gene is a recurrence predictor in primary pTa and pT1 urothelial bladder carcinoma.
Su JS; Arima K; Hasegawa M; Franco OE; Umeda Y; Yanagawa M; Sugimura Y; Kawamura J
Int J Urol; 2004 Feb; 11(2):74-82. PubMed ID: 14706010
[TBL] [Abstract][Full Text] [Related]
14. The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer.
Chen Z; Ding W; Xu K; Tan J; Sun C; Gou Y; Tong S; Xia G; Fang Z; Ding Q
PLoS One; 2012; 7(10):e47199. PubMed ID: 23082147
[TBL] [Abstract][Full Text] [Related]
15. Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression.
Mhawech P; Herrmann F; Coassin M; Guillou L; Iselin CE
Cancer; 2003 Oct; 98(8):1649-57. PubMed ID: 14534881
[TBL] [Abstract][Full Text] [Related]
16. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
[TBL] [Abstract][Full Text] [Related]
17. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
Curry JL; Wojcik EM
Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
[TBL] [Abstract][Full Text] [Related]
18. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.
Millán-Rodríguez F; Chéchile-Toniolo G; Salvador-Bayarri J; Palou J; Algaba F; Vicente-Rodríguez J
J Urol; 2000 Sep; 164(3 Pt 1):680-4. PubMed ID: 10954628
[TBL] [Abstract][Full Text] [Related]
19. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems.
Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Pauwels RP; Newling DW; ten Kate F
J Clin Pathol; 2002 Dec; 55(12):900-5. PubMed ID: 12461053
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of grade 3 superficial bladder cancer].
Shinohara M; Inoue Y; Itakura H; Munakata A; Kinoshita K
Nihon Hinyokika Gakkai Zasshi; 1996 Jun; 87(6):892-9. PubMed ID: 8753007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
